Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: Quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 7, 2003, Pages 966-973

  Thet Thet Lwin, ^a   Takeda, Tohoru ^a   Wu, Jin ^a   Fumikura, Yuko ^a   Iida, Keiji ^a   Kawano, Satoru ^a   Yamaguchi, Iwao ^a   Itai, Yuji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

123I BMIPP; 99mTc tetrofosmin; Hypertrophic cardiomyopathy; Impaired myocardial metabolism; Washout analysis

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG EXCRETION; DRUG METABOLISM; DRUG UPTAKE; DRUG WASHOUT; FEMALE; HEART LEFT VENTRICLE WALL; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HISTOLOGY; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; VALIDATION STUDY;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; FATTY ACIDS; HEART VENTRICLES; HUMANS; IODOBENZENES; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0042192113     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1163-8     Document Type: Article

References (34)

1. Tadamura E, Tamaki N, Matsumori A, Magata Y, Yonekura Y, Nohara R, Sasayama S, Yoshibayashi M, Kamiya T, Konishi J. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 1996; 37:572-577.
2. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, Kawai H, Kaneko M. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33:6-13.
3. Sugihara H, Adachi Y, Nakamura T, Ohtsuki K, Okuyama C, Ushijima Y. Long-term follow-up of myocardial perfusion and metabolic images in a patient with hypertrophic cardiomyopathy. Clin Nucl Med 2000; 25:206-230.
4. 123I-BMIPP). Nucl Med Commun 1994; 15:441-447.
5. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, Chiu KW, Edwards B, Gill H, Mcpartlin M. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34:222-227.
6. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994; 35:587-593.
7. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993; 72:1015-1019.
8. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34:1478-1484.
9. Sugihara H, Nakagawa T, Yamashita E, Kinoshita N, Ito K, Azuma A, Okuyama C, Ushijima Y, Nakagawa M, Maeda T. Reverse redistribution of Tc-99m-tetrofosmin in patients with acute myocardial infarction. Ann Nucl Med 1999; 13:43-47.
10. 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction. J Nucl Med 2001; 42:1351-1358.
11. Sugihara H, Kinosihta N, Adachi Y, Taniguchi Y, Ohtsuki K, Azuma A, Adachi H, Ushijima Y, Nakagawa M, Maeda T. Early and delayed Tc-99m-tetrofosmin myocardial SPECT in patients with left bundle branch block. Ann Nucl Med 1998; 12:281-286.
12. Sugihara H, Taniguchi Y, Kinoshita N, Nakamura T, Hirasaki S, Azuma A, Ushijima Y, Okuyama C, Nakagawa M, Maeda T. Reverse redistribution of Tc-99m-tetrofosmin in exercise myocardial SPECT in patients with hypertrophic cardiomyopathy. Ann Nucl Med 1998; 12:287-292.
13. Morishita S, Kondo Y, Nomura M, Miyajima H, Nada T, Ito S, Nakaya Y. Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol 2001; 87:743-747.
14. Maron BJ. Asymmetry in hypertrophic cardiomyopathy: the septal to free wall thickness ratio revisited. Am J Cardiol 1985; 55:835-858.
15. Henry WL, Clark CE, Epstein SE. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973; 47:225-233.
16. Maron BJ, Wolfson JK, Roberts WC. Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy. Am J Cardiol 1992; 70:785-790.
17. Unverferth DV, Baker PB, Pearce LI, Lautman J, Roberts WC. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol 1987; 59:932-936.
18. Nienaber C, Gambhir SS, Mody FV, Ratib O, Huang SC. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 1993; 87:1580-1590.
19. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II. Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995; 2:327-333.
20. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37:1551-1556.
21. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39:266-271.
22. Grover-Mckay M, Schwaiger M, Krivokapich J, Perloff JK, Phelps ME, Schelbert HR. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13:317-324.
23. Kagaya Y, Ishide N, Takeyama D, et al. Differences in myocardial fluoro-18-2-deoxyglucose uptake in young versus older patients with hypertrophic cardiomyopathy. Am J Cardiol 1992; 69:242-246.
24. Sochor H, Schelbert HR, Schwaiger M, Henze E, Phelps ME. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med 1986; 12:S66-S69.
25. Maron BJ, Ferrans VJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Morrow AG, Epstein SE. Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation 1974; 50:436-446.
26. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, Yamamoto K, Konishi J, Yokoyama A. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31:1818-1822.
27. Fujibayashi Y, Yonekura Y, Tamaki N, Yamamoto K, Som P, Knapp FF, Konishi J, Yokoyama A. Myocardial accumulation of BMIPP in relation to ATP concentration. Ann Nucl Med 1993; 7:SII-15-SII-18.
28. 131I-labeled beta-methyl-iodophenyl pentadecanoic acid in ischemic heart disease. Jpn J Nucl Med 1992; 29:347-358.
29. Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997; 38:175-180.
30. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentaadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992; 19:775-782.
31. 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy. Int J Cardiol 1996; 54:51-59.
32. Kurata C, Kobayashi A, Yamazaki N. Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 1989; 30:80-87.
33. Tadamura E, Kudoh T, Hattori N, Inubushi M, Magata Y, Konishi J, Matsumori A, Nohara R, Sasayama S, Yoshibayashi M, Tamaki N. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 1998; 38:390-396.
34. Kjaer A, Cortsen A, Rahbek B, Hasseldam H, Hesse B. Attenuation and scatter correction in myocardial SPECT: improved diagnostic accuracy in patients with suspected coronary artery disease. Eur J Nucl Med 2002; 29:1438-1442.